They aren’t the best-known corporations in the biotech industry, but they can deliver excellent long-term returns.

Problems with the central nervous system are the second leading cause of death globally, the World Health Organization determined in 2022. One reason for this situation is that it's extremely ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Three biotech stocks are making their mark, hovering around the top of the IBD 50 list, and even held all three top slots at one time over the past week. Eight biotech stocks made the list but Travere ...

Is bigger always better? Not necessarily.

(This is The Best Stocks in the Market , brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — You probably hear Sean and me talk about gaps a lot. Gaps are information.

ChatGPT will see you now. Artificial intelligence isn't quite that ubiquitous yet in hospitals or biopharma labs. Chatbots from OpenAI, Anthropic and Alphabet (GOOGL) aren't actively diagnosing ...

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

CRISPR Therapeutics is a gene editing specialist. It developed Casgevy, a medicine for two rare blood diseases, in collaboration with Vertex Pharmaceuticals. Casgevy doesn't generate much revenue yet, ...